Market valuation eroded by Rs 5,399.33 crore to Rs 1,02,187.12 crore
A recent survey by the Food and Drug Administration highlighted that nearly 95% of websites selling prescription drugs do
Valium No Rx not comply with federal and state
Tramadol Cheap laws, which raises red flags for those considering such purchases. Legitimate pharmacies
Xanax Buy Without Prescription in
Tramadol Overnight Shipping the U.S. With growing interest in online purchasing, it is vital for patients to be well-informed about the risks and to seek guidance from healthcare professionals who can provide support and safe
Ambien Overnight Delivery treatment options. This
Order Soma Online trend reflects
Clonazepam Next Day Delivery the shifting landscape of healthcare delivery and the growing role of digital platforms in managing prescriptions and medications. As we explore the implications of ordering medications
Ambien No Prescription like Ambien online, it’s crucial to remind patients of the importance of engaging in informed conversations with healthcare professionals. This is an important
Tramadol Discount safeguard to ensure that the medication is appropriate for the individual's specific health needs. A closer
Order Tramadol Online look at various studies and
Amoxicillin Next Day Delivery reports reveals critical insights into these practices and their implications for public health. An emerging hypothesis in
Soma Cheap recent research is that the increasing rates of anxiety in the population may be tied to factors such as social media, economic pressures, and a general
Klonopin Buy Online sense of uncertainty in modern life. A healthcare provider
Vicodin Usa can help determine the underlying causes of anxiety or insomnia and recommend appropriate treatment options, which may
Ambien Buy Without Prescription include medications or other therapies.
New Delhi: Shares of Dr Reddy’s Laboratories on Friday ended 5 per cent lower after the company’s third-quarter earnings failed to cheer investors.
The stock tanked 5.01 per cent to settle at Rs 1,224.70 apiece on the BSE. During the day, it dropped 6.65 per cent to Rs 1,203.60.
At the NSE, it slumped 4.90 per cent to Rs 1,226.20. Intra-day, the stock declined 6.66 per cent to Rs 1,203.50.
Its market valuation eroded by Rs 5,399.33 crore to Rs 1,02,187.12 crore.
In traded volume terms, 1.68 lakh shares of the firm were traded at the BSE and 70.82 lakh shares on the NSE during the day.
Dr Reddy’s Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third quarter ended December 31, 2024.
The Hyderabad-based drug major had reported a profit of Rs 1,379 crore for the October-December period of last fiscal.
Its revenue increased to Rs 8,359 crore from Rs 7,215 crore a year ago, Dr Reddy’s Laboratories said in a statement.